Previous Close | 2.2400 |
Open | 2.2400 |
Bid | 2.2400 x N/A |
Ask | 2.2500 x N/A |
Day's Range | 2.2400 - 2.2500 |
52 Week Range | 1.1400 - 2.2500 |
Volume | |
Avg. Volume | 209,322 |
Market Cap | 346.279M |
Beta (5Y Monthly) | 0.41 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0200 |
Earnings Date | Nov 14, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 1.66 |
Revenue of $19.4 million and Adjusted EBITDA of $3.7 million for the quarter Beverly, Massachusetts and Toronto, Ontario--(Newsfile Corp. - November 14, 2024) - Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software, and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported unaudited condensed interim financial results for the quarter and nine months ended September 30, 2024.
The TSX is having a strong year, up more than 17%, reflecting the broader market's impressive performance driven by a growing economy, favorable interest-rate policies, and rising corporate profits. In this context, identifying stocks with solid fundamentals becomes crucial for investors looking to capitalize on market opportunities. Although the term "penny stocks" might seem outdated, it still denotes smaller or emerging companies that can offer significant value; focusing on those with...